Metabolic Effect of Exercise and Diet in Endometrial Cancer Patients Eligible for Staging Surgery.
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Endometrial Cancer
Related studies linked through entity extraction aliases.
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- Status
- RECRUITING
- Phase
- PHASE1
Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance
- Status
- RECRUITING
- Phase
- N/A
Harnessing the Disease Signatures From Endometrium and Menstrual Blood to Identify Avenues for the Treatment of Chronic Conditions Such as Endometriosis and Related Pathologies: This is an Observational Study Aimed at Shedding Light on Women's Health
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
- Status
- COMPLETED
- Phase
- N/A
Radiomics and Molecular Classification in Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Sexual Health Integration in Treatment of Gynecological Oncology
- Status
- COMPLETED
- Phase
- N/A
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Status
- RECRUITING
- Phase
- PHASE3
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
OSNA Versus Ultrastaging to Detect Sentinel Lymph Node Metastasis in Endometrial Cancer
- Status
- RECRUITING
- Phase
- NA
A Study of Ivonescimab in People With Endometrial and Cervical Cancers
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan
- Status
- COMPLETED
- Phase
- N/A
QL1706-Based Therapy Post-PD-1/L1 Failure in Advanced Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE2
TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC
- Status
- RECRUITING
- Phase
- PHASE2
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- Status
- RECRUITING
- Phase
- PHASE2